Directly Compressible Co-processed Excipient for Sustained Release
978-3-659-48502-2
3659485020
108
2015-03-20
49,90 €
eng
https://images.our-assets.com/cover/230x230/9783659485022.jpg
https://images.our-assets.com/fullcover/230x230/9783659485022.jpg
https://images.our-assets.com/cover/2000x/9783659485022.jpg
https://images.our-assets.com/fullcover/2000x/9783659485022.jpg
There is a strong need for new excipient in the market to modulate flow property, compressibility, solubility, disintegration, stability, dissolution or bioavailability of drug molecule. Developing a new adjuvant is uneconomical and laborious from the standpoint of safety and regulatory clearances. Hence, the formulation scientists are constantly working on modification of existing excipients to meet the ever-changing demands of industry. Co-processed excipients are combinations of two or more excipients that possess performance advantages that cannot be achieved using a physical admixture of the same combination of excipients. Present research work deals with development of multifunctional excipient, co-processed glyceryl monostearate- dicalcium phosphate dihydrate, to improve flowability and compressibility of the blend and to provide sustained release of highly water soluble drug, tramadol hydrochloride. There are a wide variety of drugs in whose formulation the prepared co-processed excipient of glycerylmonostearate and dicalcium phosphate dihydrate can be used. Hence, its commercial viability needs to be exploited in all case.
https://www.morebooks.de/books/de/published_by/lap-lambert-academic-publishing/47/products
Sonstiges
https://www.morebooks.de/store/de/book/directly-compressible-co-processed-excipient-for-sustained-release/isbn/978-3-659-48502-2